Global Passive Transdermal Drug Delivery Device Market Growth 2026-2032
The global Passive Transdermal Drug Delivery Device market size is predicted to grow from US$ 4891 million in 2025 to US$ 7047 million in 2032; it is expected to grow at a CAGR of 5.1% from 2026 to 2032.
A passive transdermal drug delivery device refers to a category of drug delivery instruments that rely solely on the drug's own diffusion characteristics to penetrate the skin barrier and enter the body to exert therapeutic effects. Its technical essence lies in utilizing the concentration gradient as the driving force, allowing drug molecules to naturally diffuse from high-concentration areas to low-concentration areas without the need for any external energy. From a product morphology perspective, the transdermal patch is the most typical representative of passive transdermal drug delivery devices, typically consisting of a backing layer, drug reservoir, adhesive layer, rate-controlling membrane, and release liner, achieving controlled drug dosage by adjusting the application duration. According to a 2011 technical article in Electronic Technology Application, external patches are the most commonly used passive drug delivery method, safely and comfortably delivering a certain dose of medication to patients over a defined period, with the drug entering the bloodstream through skin absorption. Nicotine patches are the classic example of such devices, with other common applications including motion sickness treatment, hormone replacement therapy, and contraception. Additionally, gels, plasters, microemulsions, and flexible liposomes (such as transfersomes) also fall within the category of passive transdermal drug delivery. A 2024 review in Molecular Pharmaceutics noted that transdermal drug delivery systems (TDDS) have become an important technology platform in the field of drug delivery due to their non-invasive nature, patient convenience, and ability to bypass first-pass metabolism associated with oral administration. Currently, passive transdermal drug delivery devices are expanding from traditional small-molecule drug delivery toward the delivery of biologics such as peptides and proteins, with their industrial value continuing to grow alongside the increasing demand for chronic disease management.
Market Development Opportunities and Key Drivers
A 2025 study published in the Journal of Nanobiotechnology proposed a two-stage transdermal drug delivery system based on sonophase-change transfersomes (SPCTs), combining passive penetration with ultrasound-triggered active permeation. Kindeva noted in January 2026 that skin delivery is gaining increasing attention, with patients and healthcare systems seeking needle-free, home-based drug delivery options. A 2024 review in Molecular Pharmaceutics systematically analyzed the development and failure modes of transdermal drug delivery systems, providing the industry with strategies for risk mitigation. The long-term treatment needs of chronic disease management are driving expanded insurance coverage for transdermal drug delivery devices.
Market Challenges and Risks
Skin impedance is complex and variable, influenced by factors such as age, ethnicity, and body weight, making precise control of drug absorption rates difficult. Currently, only small-molecule lipophilic drugs with molecular weights below 500 Da can penetrate the skin barrier at acceptable rates. While novel carriers such as transfersomes and microemulsions can enhance the transdermal penetration of macromolecular drugs, their industrial-scale manufacturing processes, batch consistency, and long-term stability still require validation. The adhesive system itself can also be a source of failure, as certain adhesives may not be suitable for all skin types and their properties can be affected by sweating, bathing, or swimming.
Downstream Demand Trends
Transdermal patches for drugs such as fentanyl and buprenorphine have become a long-term treatment option for moderate to severe pain. Transdermal drug delivery systems have been applied to a range of drugs including nicotine, fentanyl, nitroglycerin, and clonidine, with ongoing exploration of their potential for biologic delivery. Nitroglycerin patches are used for angina prophylaxis, clonidine patches for hypertension treatment, and rivastigmine patches for Alzheimer's disease, offering an alternative route for patients with dysphagia. Contraceptive patches and hormone replacement patches are well-established products, while transdermal patches containing active ingredients such as caffeine and vitamins are entering the market as functional consumer goods.
Regional Trends
North America, leveraging its mature innovation ecosystem and rapid regulatory pathways, continues to lead source innovation in transdermal drug delivery technology, with CDMOs such as Kindeva providing end-to-end services from formulation development to large-scale manufacturing. Europe maintains its advantage in basic research and clinical evidence accumulation, with Germany's LTS Lohmann Therapie-Systeme AG holding over 20 marketed products and more than 50 projects in development. In the Asia-Pacific region, China is emerging as the most dynamic growth market. Domestic companies such as MicroCore have achieved mass production of microneedle patches, with an annual capacity in the tens of millions of units; Jiangsu Kangbeide Pharmaceutical possesses three platform technologies for transdermal formulations and has passed GMP inspections. Universities such as East China University of Science and Technology continue to generate innovations in novel carriers such as transfersomes and flexible liposomes.
LP Information, Inc. (LPI) ' newest research report, the ?Passive Transdermal Drug Delivery Device Industry Forecast? looks at past sales and reviews total world Passive Transdermal Drug Delivery Device sales in 2025, providing a comprehensive analysis by region and market sector of projected Passive Transdermal Drug Delivery Device sales for 2026 through 2032. With Passive Transdermal Drug Delivery Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Passive Transdermal Drug Delivery Device industry.
This Insight Report provides a comprehensive analysis of the global Passive Transdermal Drug Delivery Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Passive Transdermal Drug Delivery Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Passive Transdermal Drug Delivery Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Passive Transdermal Drug Delivery Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Passive Transdermal Drug Delivery Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Passive Transdermal Drug Delivery Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Passive Transdermal Drug Delivery Device market?
What factors are driving Passive Transdermal Drug Delivery Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Passive Transdermal Drug Delivery Device market opportunities vary by end market size?
How does Passive Transdermal Drug Delivery Device break out by Type, by Application?
A passive transdermal drug delivery device refers to a category of drug delivery instruments that rely solely on the drug's own diffusion characteristics to penetrate the skin barrier and enter the body to exert therapeutic effects. Its technical essence lies in utilizing the concentration gradient as the driving force, allowing drug molecules to naturally diffuse from high-concentration areas to low-concentration areas without the need for any external energy. From a product morphology perspective, the transdermal patch is the most typical representative of passive transdermal drug delivery devices, typically consisting of a backing layer, drug reservoir, adhesive layer, rate-controlling membrane, and release liner, achieving controlled drug dosage by adjusting the application duration. According to a 2011 technical article in Electronic Technology Application, external patches are the most commonly used passive drug delivery method, safely and comfortably delivering a certain dose of medication to patients over a defined period, with the drug entering the bloodstream through skin absorption. Nicotine patches are the classic example of such devices, with other common applications including motion sickness treatment, hormone replacement therapy, and contraception. Additionally, gels, plasters, microemulsions, and flexible liposomes (such as transfersomes) also fall within the category of passive transdermal drug delivery. A 2024 review in Molecular Pharmaceutics noted that transdermal drug delivery systems (TDDS) have become an important technology platform in the field of drug delivery due to their non-invasive nature, patient convenience, and ability to bypass first-pass metabolism associated with oral administration. Currently, passive transdermal drug delivery devices are expanding from traditional small-molecule drug delivery toward the delivery of biologics such as peptides and proteins, with their industrial value continuing to grow alongside the increasing demand for chronic disease management.
Market Development Opportunities and Key Drivers
A 2025 study published in the Journal of Nanobiotechnology proposed a two-stage transdermal drug delivery system based on sonophase-change transfersomes (SPCTs), combining passive penetration with ultrasound-triggered active permeation. Kindeva noted in January 2026 that skin delivery is gaining increasing attention, with patients and healthcare systems seeking needle-free, home-based drug delivery options. A 2024 review in Molecular Pharmaceutics systematically analyzed the development and failure modes of transdermal drug delivery systems, providing the industry with strategies for risk mitigation. The long-term treatment needs of chronic disease management are driving expanded insurance coverage for transdermal drug delivery devices.
Market Challenges and Risks
Skin impedance is complex and variable, influenced by factors such as age, ethnicity, and body weight, making precise control of drug absorption rates difficult. Currently, only small-molecule lipophilic drugs with molecular weights below 500 Da can penetrate the skin barrier at acceptable rates. While novel carriers such as transfersomes and microemulsions can enhance the transdermal penetration of macromolecular drugs, their industrial-scale manufacturing processes, batch consistency, and long-term stability still require validation. The adhesive system itself can also be a source of failure, as certain adhesives may not be suitable for all skin types and their properties can be affected by sweating, bathing, or swimming.
Downstream Demand Trends
Transdermal patches for drugs such as fentanyl and buprenorphine have become a long-term treatment option for moderate to severe pain. Transdermal drug delivery systems have been applied to a range of drugs including nicotine, fentanyl, nitroglycerin, and clonidine, with ongoing exploration of their potential for biologic delivery. Nitroglycerin patches are used for angina prophylaxis, clonidine patches for hypertension treatment, and rivastigmine patches for Alzheimer's disease, offering an alternative route for patients with dysphagia. Contraceptive patches and hormone replacement patches are well-established products, while transdermal patches containing active ingredients such as caffeine and vitamins are entering the market as functional consumer goods.
Regional Trends
North America, leveraging its mature innovation ecosystem and rapid regulatory pathways, continues to lead source innovation in transdermal drug delivery technology, with CDMOs such as Kindeva providing end-to-end services from formulation development to large-scale manufacturing. Europe maintains its advantage in basic research and clinical evidence accumulation, with Germany's LTS Lohmann Therapie-Systeme AG holding over 20 marketed products and more than 50 projects in development. In the Asia-Pacific region, China is emerging as the most dynamic growth market. Domestic companies such as MicroCore have achieved mass production of microneedle patches, with an annual capacity in the tens of millions of units; Jiangsu Kangbeide Pharmaceutical possesses three platform technologies for transdermal formulations and has passed GMP inspections. Universities such as East China University of Science and Technology continue to generate innovations in novel carriers such as transfersomes and flexible liposomes.
LP Information, Inc. (LPI) ' newest research report, the ?Passive Transdermal Drug Delivery Device Industry Forecast? looks at past sales and reviews total world Passive Transdermal Drug Delivery Device sales in 2025, providing a comprehensive analysis by region and market sector of projected Passive Transdermal Drug Delivery Device sales for 2026 through 2032. With Passive Transdermal Drug Delivery Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Passive Transdermal Drug Delivery Device industry.
This Insight Report provides a comprehensive analysis of the global Passive Transdermal Drug Delivery Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Passive Transdermal Drug Delivery Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Passive Transdermal Drug Delivery Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Passive Transdermal Drug Delivery Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Passive Transdermal Drug Delivery Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Passive Transdermal Drug Delivery Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Patch Drug Delivery
- Cream Drug Delivery
- Plaster Drug Delivery
- Microneedle Drug Delivery
- Liposome Drug Delivery
- Small Molecule Drugs
- Protein Drugs
- Nucleic Acid Drugs
- Diffusion Only Drug Delivery
- Penetration Enhancer Assisted Drug Delivery
- Carrier Mediated Drug Delivery
- Immediate Release Drug Delivery
- Sustained Release Drug Delivery
- Controlled Release Drug Delivery
- Neurological Disorders Treatment
- Cardiovascular Diseases Treatment
- Hormone Replacement Therapy
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Hisamitsu
- LTS Lohmann Therapie-Systeme
- Teikoku
- Nitto Denko
- MedPharm
- NexGel
- Kindeva Drug Delivery
- Noven
- Teikoku Seiyaku
- Ildong Pharmaceutical
- PassPort Technologies
- Hayao Group
- Lingrui Pharmaceutical
- CAS Microneedle
- Luye
- Tide Pharmaceutical
- Jiudian Pharmaceutical
- LianSN Pharm
What is the 10-year outlook for the global Passive Transdermal Drug Delivery Device market?
What factors are driving Passive Transdermal Drug Delivery Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Passive Transdermal Drug Delivery Device market opportunities vary by end market size?
How does Passive Transdermal Drug Delivery Device break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Passive Transdermal Drug Delivery Device Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Passive Transdermal Drug Delivery Device by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Passive Transdermal Drug Delivery Device by Country/Region, 2021, 2025 & 2032
2.2 Passive Transdermal Drug Delivery Device Segment by Type
2.2.1 Patch Drug Delivery
2.2.2 Cream Drug Delivery
2.2.3 Plaster Drug Delivery
2.2.4 Microneedle Drug Delivery
2.2.5 Liposome Drug Delivery
2.2.6 Passive Transdermal Drug Delivery Device Sales by Type
2.2.6.1 Global Passive Transdermal Drug Delivery Device Sales Market Share by Type (2021-2026)
2.2.6.2 Global Passive Transdermal Drug Delivery Device Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Passive Transdermal Drug Delivery Device Sale Price by Type (2021-2026)
2.3 Passive Transdermal Drug Delivery Device Segment by Drug Type
2.3.1 Small Molecule Drugs
2.3.2 Protein Drugs
2.3.3 Nucleic Acid Drugs
2.3.4 Passive Transdermal Drug Delivery Device Sales by Drug Type
2.3.4.1 Global Passive Transdermal Drug Delivery Device Sales Market Share by Drug Type (2021-2026)
2.3.4.2 Global Passive Transdermal Drug Delivery Device Revenue and Market Share by Drug Type (2021-2026)
2.3.4.3 Global Passive Transdermal Drug Delivery Device Sale Price by Drug Type (2021-2026)
2.4 Passive Transdermal Drug Delivery Device Segment by Interaction Mechanism
2.4.1 Diffusion Only Drug Delivery
2.4.2 Penetration Enhancer Assisted Drug Delivery
2.4.3 Carrier Mediated Drug Delivery
2.4.4 Passive Transdermal Drug Delivery Device Sales by Interaction Mechanism
2.4.4.1 Global Passive Transdermal Drug Delivery Device Sales Market Share by Interaction Mechanism (2021-2026)
2.4.4.2 Global Passive Transdermal Drug Delivery Device Revenue and Market Share by Interaction Mechanism (2021-2026)
2.4.4.3 Global Passive Transdermal Drug Delivery Device Sale Price by Interaction Mechanism (2021-2026)
2.5 Passive Transdermal Drug Delivery Device Segment by Drug Release Rate
2.5.1 Immediate Release Drug Delivery
2.5.2 Sustained Release Drug Delivery
2.5.3 Controlled Release Drug Delivery
2.5.4 Passive Transdermal Drug Delivery Device Sales by Drug Release Rate
2.5.4.1 Global Passive Transdermal Drug Delivery Device Sales Market Share by Drug Release Rate (2021-2026)
2.5.4.2 Global Passive Transdermal Drug Delivery Device Revenue and Market Share by Drug Release Rate (2021-2026)
2.5.4.3 Global Passive Transdermal Drug Delivery Device Sale Price by Drug Release Rate (2021-2026)
2.6 Passive Transdermal Drug Delivery Device Segment by Application
2.6.1 Neurological Disorders Treatment
2.6.2 Cardiovascular Diseases Treatment
2.6.3 Hormone Replacement Therapy
2.6.4 Passive Transdermal Drug Delivery Device Sales by Application
2.6.4.1 Global Passive Transdermal Drug Delivery Device Sale Market Share by Application (2021-2026)
2.6.4.2 Global Passive Transdermal Drug Delivery Device Revenue and Market Share by Application (2021-2026)
2.6.4.3 Global Passive Transdermal Drug Delivery Device Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Passive Transdermal Drug Delivery Device Breakdown Data by Company
3.1.1 Global Passive Transdermal Drug Delivery Device Annual Sales by Company (2021-2026)
3.1.2 Global Passive Transdermal Drug Delivery Device Sales Market Share by Company (2021-2026)
3.2 Global Passive Transdermal Drug Delivery Device Annual Revenue by Company (2021-2026)
3.2.1 Global Passive Transdermal Drug Delivery Device Revenue by Company (2021-2026)
3.2.2 Global Passive Transdermal Drug Delivery Device Revenue Market Share by Company (2021-2026)
3.3 Global Passive Transdermal Drug Delivery Device Sale Price by Company
3.4 Key Manufacturers Passive Transdermal Drug Delivery Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Passive Transdermal Drug Delivery Device Product Location Distribution
3.4.2 Players Passive Transdermal Drug Delivery Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PASSIVE TRANSDERMAL DRUG DELIVERY DEVICE BY GEOGRAPHIC REGION
4.1 World Historic Passive Transdermal Drug Delivery Device Market Size by Geographic Region (2021-2026)
4.1.1 Global Passive Transdermal Drug Delivery Device Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Passive Transdermal Drug Delivery Device Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Passive Transdermal Drug Delivery Device Market Size by Country/Region (2021-2026)
4.2.1 Global Passive Transdermal Drug Delivery Device Annual Sales by Country/Region (2021-2026)
4.2.2 Global Passive Transdermal Drug Delivery Device Annual Revenue by Country/Region (2021-2026)
4.3 Americas Passive Transdermal Drug Delivery Device Sales Growth
4.4 APAC Passive Transdermal Drug Delivery Device Sales Growth
4.5 Europe Passive Transdermal Drug Delivery Device Sales Growth
4.6 Middle East & Africa Passive Transdermal Drug Delivery Device Sales Growth
5 AMERICAS
5.1 Americas Passive Transdermal Drug Delivery Device Sales by Country
5.1.1 Americas Passive Transdermal Drug Delivery Device Sales by Country (2021-2026)
5.1.2 Americas Passive Transdermal Drug Delivery Device Revenue by Country (2021-2026)
5.2 Americas Passive Transdermal Drug Delivery Device Sales by Type (2021-2026)
5.3 Americas Passive Transdermal Drug Delivery Device Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Passive Transdermal Drug Delivery Device Sales by Region
6.1.1 APAC Passive Transdermal Drug Delivery Device Sales by Region (2021-2026)
6.1.2 APAC Passive Transdermal Drug Delivery Device Revenue by Region (2021-2026)
6.2 APAC Passive Transdermal Drug Delivery Device Sales by Type (2021-2026)
6.3 APAC Passive Transdermal Drug Delivery Device Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Passive Transdermal Drug Delivery Device by Country
7.1.1 Europe Passive Transdermal Drug Delivery Device Sales by Country (2021-2026)
7.1.2 Europe Passive Transdermal Drug Delivery Device Revenue by Country (2021-2026)
7.2 Europe Passive Transdermal Drug Delivery Device Sales by Type (2021-2026)
7.3 Europe Passive Transdermal Drug Delivery Device Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Passive Transdermal Drug Delivery Device by Country
8.1.1 Middle East & Africa Passive Transdermal Drug Delivery Device Sales by Country (2021-2026)
8.1.2 Middle East & Africa Passive Transdermal Drug Delivery Device Revenue by Country (2021-2026)
8.2 Middle East & Africa Passive Transdermal Drug Delivery Device Sales by Type (2021-2026)
8.3 Middle East & Africa Passive Transdermal Drug Delivery Device Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Passive Transdermal Drug Delivery Device
10.3 Manufacturing Process Analysis of Passive Transdermal Drug Delivery Device
10.4 Industry Chain Structure of Passive Transdermal Drug Delivery Device
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Passive Transdermal Drug Delivery Device Distributors
11.3 Passive Transdermal Drug Delivery Device Customer
12 WORLD FORECAST REVIEW FOR PASSIVE TRANSDERMAL DRUG DELIVERY DEVICE BY GEOGRAPHIC REGION
12.1 Global Passive Transdermal Drug Delivery Device Market Size Forecast by Region
12.1.1 Global Passive Transdermal Drug Delivery Device Forecast by Region (2027-2032)
12.1.2 Global Passive Transdermal Drug Delivery Device Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Passive Transdermal Drug Delivery Device Forecast by Type (2027-2032)
12.7 Global Passive Transdermal Drug Delivery Device Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Hisamitsu
13.1.1 Hisamitsu Company Information
13.1.2 Hisamitsu Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.1.3 Hisamitsu Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Hisamitsu Main Business Overview
13.1.5 Hisamitsu Latest Developments
13.2 LTS Lohmann Therapie-Systeme
13.2.1 LTS Lohmann Therapie-Systeme Company Information
13.2.2 LTS Lohmann Therapie-Systeme Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.2.3 LTS Lohmann Therapie-Systeme Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 LTS Lohmann Therapie-Systeme Main Business Overview
13.2.5 LTS Lohmann Therapie-Systeme Latest Developments
13.3 Teikoku
13.3.1 Teikoku Company Information
13.3.2 Teikoku Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.3.3 Teikoku Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Teikoku Main Business Overview
13.3.5 Teikoku Latest Developments
13.4 Nitto Denko
13.4.1 Nitto Denko Company Information
13.4.2 Nitto Denko Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.4.3 Nitto Denko Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Nitto Denko Main Business Overview
13.4.5 Nitto Denko Latest Developments
13.5 MedPharm
13.5.1 MedPharm Company Information
13.5.2 MedPharm Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.5.3 MedPharm Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 MedPharm Main Business Overview
13.5.5 MedPharm Latest Developments
13.6 NexGel
13.6.1 NexGel Company Information
13.6.2 NexGel Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.6.3 NexGel Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 NexGel Main Business Overview
13.6.5 NexGel Latest Developments
13.7 Kindeva Drug Delivery
13.7.1 Kindeva Drug Delivery Company Information
13.7.2 Kindeva Drug Delivery Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.7.3 Kindeva Drug Delivery Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Kindeva Drug Delivery Main Business Overview
13.7.5 Kindeva Drug Delivery Latest Developments
13.8 Noven
13.8.1 Noven Company Information
13.8.2 Noven Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.8.3 Noven Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Noven Main Business Overview
13.8.5 Noven Latest Developments
13.9 Teikoku Seiyaku
13.9.1 Teikoku Seiyaku Company Information
13.9.2 Teikoku Seiyaku Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.9.3 Teikoku Seiyaku Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Teikoku Seiyaku Main Business Overview
13.9.5 Teikoku Seiyaku Latest Developments
13.10 Ildong Pharmaceutical
13.10.1 Ildong Pharmaceutical Company Information
13.10.2 Ildong Pharmaceutical Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.10.3 Ildong Pharmaceutical Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Ildong Pharmaceutical Main Business Overview
13.10.5 Ildong Pharmaceutical Latest Developments
13.11 PassPort Technologies
13.11.1 PassPort Technologies Company Information
13.11.2 PassPort Technologies Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.11.3 PassPort Technologies Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 PassPort Technologies Main Business Overview
13.11.5 PassPort Technologies Latest Developments
13.12 Hayao Group
13.12.1 Hayao Group Company Information
13.12.2 Hayao Group Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.12.3 Hayao Group Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Hayao Group Main Business Overview
13.12.5 Hayao Group Latest Developments
13.13 Lingrui Pharmaceutical
13.13.1 Lingrui Pharmaceutical Company Information
13.13.2 Lingrui Pharmaceutical Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.13.3 Lingrui Pharmaceutical Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Lingrui Pharmaceutical Main Business Overview
13.13.5 Lingrui Pharmaceutical Latest Developments
13.14 CAS Microneedle
13.14.1 CAS Microneedle Company Information
13.14.2 CAS Microneedle Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.14.3 CAS Microneedle Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 CAS Microneedle Main Business Overview
13.14.5 CAS Microneedle Latest Developments
13.15 Luye
13.15.1 Luye Company Information
13.15.2 Luye Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.15.3 Luye Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Luye Main Business Overview
13.15.5 Luye Latest Developments
13.16 Tide Pharmaceutical
13.16.1 Tide Pharmaceutical Company Information
13.16.2 Tide Pharmaceutical Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.16.3 Tide Pharmaceutical Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Tide Pharmaceutical Main Business Overview
13.16.5 Tide Pharmaceutical Latest Developments
13.17 Jiudian Pharmaceutical
13.17.1 Jiudian Pharmaceutical Company Information
13.17.2 Jiudian Pharmaceutical Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.17.3 Jiudian Pharmaceutical Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Jiudian Pharmaceutical Main Business Overview
13.17.5 Jiudian Pharmaceutical Latest Developments
13.18 LianSN Pharm
13.18.1 LianSN Pharm Company Information
13.18.2 LianSN Pharm Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.18.3 LianSN Pharm Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 LianSN Pharm Main Business Overview
13.18.5 LianSN Pharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Passive Transdermal Drug Delivery Device Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Passive Transdermal Drug Delivery Device by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Passive Transdermal Drug Delivery Device by Country/Region, 2021, 2025 & 2032
2.2 Passive Transdermal Drug Delivery Device Segment by Type
2.2.1 Patch Drug Delivery
2.2.2 Cream Drug Delivery
2.2.3 Plaster Drug Delivery
2.2.4 Microneedle Drug Delivery
2.2.5 Liposome Drug Delivery
2.2.6 Passive Transdermal Drug Delivery Device Sales by Type
2.2.6.1 Global Passive Transdermal Drug Delivery Device Sales Market Share by Type (2021-2026)
2.2.6.2 Global Passive Transdermal Drug Delivery Device Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Passive Transdermal Drug Delivery Device Sale Price by Type (2021-2026)
2.3 Passive Transdermal Drug Delivery Device Segment by Drug Type
2.3.1 Small Molecule Drugs
2.3.2 Protein Drugs
2.3.3 Nucleic Acid Drugs
2.3.4 Passive Transdermal Drug Delivery Device Sales by Drug Type
2.3.4.1 Global Passive Transdermal Drug Delivery Device Sales Market Share by Drug Type (2021-2026)
2.3.4.2 Global Passive Transdermal Drug Delivery Device Revenue and Market Share by Drug Type (2021-2026)
2.3.4.3 Global Passive Transdermal Drug Delivery Device Sale Price by Drug Type (2021-2026)
2.4 Passive Transdermal Drug Delivery Device Segment by Interaction Mechanism
2.4.1 Diffusion Only Drug Delivery
2.4.2 Penetration Enhancer Assisted Drug Delivery
2.4.3 Carrier Mediated Drug Delivery
2.4.4 Passive Transdermal Drug Delivery Device Sales by Interaction Mechanism
2.4.4.1 Global Passive Transdermal Drug Delivery Device Sales Market Share by Interaction Mechanism (2021-2026)
2.4.4.2 Global Passive Transdermal Drug Delivery Device Revenue and Market Share by Interaction Mechanism (2021-2026)
2.4.4.3 Global Passive Transdermal Drug Delivery Device Sale Price by Interaction Mechanism (2021-2026)
2.5 Passive Transdermal Drug Delivery Device Segment by Drug Release Rate
2.5.1 Immediate Release Drug Delivery
2.5.2 Sustained Release Drug Delivery
2.5.3 Controlled Release Drug Delivery
2.5.4 Passive Transdermal Drug Delivery Device Sales by Drug Release Rate
2.5.4.1 Global Passive Transdermal Drug Delivery Device Sales Market Share by Drug Release Rate (2021-2026)
2.5.4.2 Global Passive Transdermal Drug Delivery Device Revenue and Market Share by Drug Release Rate (2021-2026)
2.5.4.3 Global Passive Transdermal Drug Delivery Device Sale Price by Drug Release Rate (2021-2026)
2.6 Passive Transdermal Drug Delivery Device Segment by Application
2.6.1 Neurological Disorders Treatment
2.6.2 Cardiovascular Diseases Treatment
2.6.3 Hormone Replacement Therapy
2.6.4 Passive Transdermal Drug Delivery Device Sales by Application
2.6.4.1 Global Passive Transdermal Drug Delivery Device Sale Market Share by Application (2021-2026)
2.6.4.2 Global Passive Transdermal Drug Delivery Device Revenue and Market Share by Application (2021-2026)
2.6.4.3 Global Passive Transdermal Drug Delivery Device Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Passive Transdermal Drug Delivery Device Breakdown Data by Company
3.1.1 Global Passive Transdermal Drug Delivery Device Annual Sales by Company (2021-2026)
3.1.2 Global Passive Transdermal Drug Delivery Device Sales Market Share by Company (2021-2026)
3.2 Global Passive Transdermal Drug Delivery Device Annual Revenue by Company (2021-2026)
3.2.1 Global Passive Transdermal Drug Delivery Device Revenue by Company (2021-2026)
3.2.2 Global Passive Transdermal Drug Delivery Device Revenue Market Share by Company (2021-2026)
3.3 Global Passive Transdermal Drug Delivery Device Sale Price by Company
3.4 Key Manufacturers Passive Transdermal Drug Delivery Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Passive Transdermal Drug Delivery Device Product Location Distribution
3.4.2 Players Passive Transdermal Drug Delivery Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PASSIVE TRANSDERMAL DRUG DELIVERY DEVICE BY GEOGRAPHIC REGION
4.1 World Historic Passive Transdermal Drug Delivery Device Market Size by Geographic Region (2021-2026)
4.1.1 Global Passive Transdermal Drug Delivery Device Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Passive Transdermal Drug Delivery Device Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Passive Transdermal Drug Delivery Device Market Size by Country/Region (2021-2026)
4.2.1 Global Passive Transdermal Drug Delivery Device Annual Sales by Country/Region (2021-2026)
4.2.2 Global Passive Transdermal Drug Delivery Device Annual Revenue by Country/Region (2021-2026)
4.3 Americas Passive Transdermal Drug Delivery Device Sales Growth
4.4 APAC Passive Transdermal Drug Delivery Device Sales Growth
4.5 Europe Passive Transdermal Drug Delivery Device Sales Growth
4.6 Middle East & Africa Passive Transdermal Drug Delivery Device Sales Growth
5 AMERICAS
5.1 Americas Passive Transdermal Drug Delivery Device Sales by Country
5.1.1 Americas Passive Transdermal Drug Delivery Device Sales by Country (2021-2026)
5.1.2 Americas Passive Transdermal Drug Delivery Device Revenue by Country (2021-2026)
5.2 Americas Passive Transdermal Drug Delivery Device Sales by Type (2021-2026)
5.3 Americas Passive Transdermal Drug Delivery Device Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Passive Transdermal Drug Delivery Device Sales by Region
6.1.1 APAC Passive Transdermal Drug Delivery Device Sales by Region (2021-2026)
6.1.2 APAC Passive Transdermal Drug Delivery Device Revenue by Region (2021-2026)
6.2 APAC Passive Transdermal Drug Delivery Device Sales by Type (2021-2026)
6.3 APAC Passive Transdermal Drug Delivery Device Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Passive Transdermal Drug Delivery Device by Country
7.1.1 Europe Passive Transdermal Drug Delivery Device Sales by Country (2021-2026)
7.1.2 Europe Passive Transdermal Drug Delivery Device Revenue by Country (2021-2026)
7.2 Europe Passive Transdermal Drug Delivery Device Sales by Type (2021-2026)
7.3 Europe Passive Transdermal Drug Delivery Device Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Passive Transdermal Drug Delivery Device by Country
8.1.1 Middle East & Africa Passive Transdermal Drug Delivery Device Sales by Country (2021-2026)
8.1.2 Middle East & Africa Passive Transdermal Drug Delivery Device Revenue by Country (2021-2026)
8.2 Middle East & Africa Passive Transdermal Drug Delivery Device Sales by Type (2021-2026)
8.3 Middle East & Africa Passive Transdermal Drug Delivery Device Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Passive Transdermal Drug Delivery Device
10.3 Manufacturing Process Analysis of Passive Transdermal Drug Delivery Device
10.4 Industry Chain Structure of Passive Transdermal Drug Delivery Device
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Passive Transdermal Drug Delivery Device Distributors
11.3 Passive Transdermal Drug Delivery Device Customer
12 WORLD FORECAST REVIEW FOR PASSIVE TRANSDERMAL DRUG DELIVERY DEVICE BY GEOGRAPHIC REGION
12.1 Global Passive Transdermal Drug Delivery Device Market Size Forecast by Region
12.1.1 Global Passive Transdermal Drug Delivery Device Forecast by Region (2027-2032)
12.1.2 Global Passive Transdermal Drug Delivery Device Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Passive Transdermal Drug Delivery Device Forecast by Type (2027-2032)
12.7 Global Passive Transdermal Drug Delivery Device Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Hisamitsu
13.1.1 Hisamitsu Company Information
13.1.2 Hisamitsu Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.1.3 Hisamitsu Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Hisamitsu Main Business Overview
13.1.5 Hisamitsu Latest Developments
13.2 LTS Lohmann Therapie-Systeme
13.2.1 LTS Lohmann Therapie-Systeme Company Information
13.2.2 LTS Lohmann Therapie-Systeme Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.2.3 LTS Lohmann Therapie-Systeme Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 LTS Lohmann Therapie-Systeme Main Business Overview
13.2.5 LTS Lohmann Therapie-Systeme Latest Developments
13.3 Teikoku
13.3.1 Teikoku Company Information
13.3.2 Teikoku Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.3.3 Teikoku Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Teikoku Main Business Overview
13.3.5 Teikoku Latest Developments
13.4 Nitto Denko
13.4.1 Nitto Denko Company Information
13.4.2 Nitto Denko Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.4.3 Nitto Denko Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Nitto Denko Main Business Overview
13.4.5 Nitto Denko Latest Developments
13.5 MedPharm
13.5.1 MedPharm Company Information
13.5.2 MedPharm Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.5.3 MedPharm Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 MedPharm Main Business Overview
13.5.5 MedPharm Latest Developments
13.6 NexGel
13.6.1 NexGel Company Information
13.6.2 NexGel Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.6.3 NexGel Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 NexGel Main Business Overview
13.6.5 NexGel Latest Developments
13.7 Kindeva Drug Delivery
13.7.1 Kindeva Drug Delivery Company Information
13.7.2 Kindeva Drug Delivery Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.7.3 Kindeva Drug Delivery Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Kindeva Drug Delivery Main Business Overview
13.7.5 Kindeva Drug Delivery Latest Developments
13.8 Noven
13.8.1 Noven Company Information
13.8.2 Noven Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.8.3 Noven Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Noven Main Business Overview
13.8.5 Noven Latest Developments
13.9 Teikoku Seiyaku
13.9.1 Teikoku Seiyaku Company Information
13.9.2 Teikoku Seiyaku Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.9.3 Teikoku Seiyaku Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Teikoku Seiyaku Main Business Overview
13.9.5 Teikoku Seiyaku Latest Developments
13.10 Ildong Pharmaceutical
13.10.1 Ildong Pharmaceutical Company Information
13.10.2 Ildong Pharmaceutical Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.10.3 Ildong Pharmaceutical Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Ildong Pharmaceutical Main Business Overview
13.10.5 Ildong Pharmaceutical Latest Developments
13.11 PassPort Technologies
13.11.1 PassPort Technologies Company Information
13.11.2 PassPort Technologies Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.11.3 PassPort Technologies Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 PassPort Technologies Main Business Overview
13.11.5 PassPort Technologies Latest Developments
13.12 Hayao Group
13.12.1 Hayao Group Company Information
13.12.2 Hayao Group Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.12.3 Hayao Group Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Hayao Group Main Business Overview
13.12.5 Hayao Group Latest Developments
13.13 Lingrui Pharmaceutical
13.13.1 Lingrui Pharmaceutical Company Information
13.13.2 Lingrui Pharmaceutical Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.13.3 Lingrui Pharmaceutical Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Lingrui Pharmaceutical Main Business Overview
13.13.5 Lingrui Pharmaceutical Latest Developments
13.14 CAS Microneedle
13.14.1 CAS Microneedle Company Information
13.14.2 CAS Microneedle Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.14.3 CAS Microneedle Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 CAS Microneedle Main Business Overview
13.14.5 CAS Microneedle Latest Developments
13.15 Luye
13.15.1 Luye Company Information
13.15.2 Luye Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.15.3 Luye Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Luye Main Business Overview
13.15.5 Luye Latest Developments
13.16 Tide Pharmaceutical
13.16.1 Tide Pharmaceutical Company Information
13.16.2 Tide Pharmaceutical Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.16.3 Tide Pharmaceutical Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Tide Pharmaceutical Main Business Overview
13.16.5 Tide Pharmaceutical Latest Developments
13.17 Jiudian Pharmaceutical
13.17.1 Jiudian Pharmaceutical Company Information
13.17.2 Jiudian Pharmaceutical Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.17.3 Jiudian Pharmaceutical Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Jiudian Pharmaceutical Main Business Overview
13.17.5 Jiudian Pharmaceutical Latest Developments
13.18 LianSN Pharm
13.18.1 LianSN Pharm Company Information
13.18.2 LianSN Pharm Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
13.18.3 LianSN Pharm Passive Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 LianSN Pharm Main Business Overview
13.18.5 LianSN Pharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Passive Transdermal Drug Delivery Device Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Passive Transdermal Drug Delivery Device Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Patch Drug Delivery
Table 4. Major Players of Cream Drug Delivery
Table 5. Major Players of Plaster Drug Delivery
Table 6. Major Players of Microneedle Drug Delivery
Table 7. Major Players of Liposome Drug Delivery
Table 8. Global Passive Transdermal Drug Delivery Device Sales by Type (2021-2026) & (Units)
Table 9. Global Passive Transdermal Drug Delivery Device Sales Market Share by Type (2021-2026)
Table 10. Global Passive Transdermal Drug Delivery Device Revenue by Type (2021-2026) & ($ million)
Table 11. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Type (2021-2026)
Table 12. Global Passive Transdermal Drug Delivery Device Sale Price by Type (2021-2026) & (USD/Unit)
Table 13. Major Players of Small Molecule Drugs
Table 14. Major Players of Protein Drugs
Table 15. Major Players of Nucleic Acid Drugs
Table 16. Global Passive Transdermal Drug Delivery Device Sales by Drug Type (2021-2026) & (Units)
Table 17. Global Passive Transdermal Drug Delivery Device Sales Market Share by Drug Type (2021-2026)
Table 18. Global Passive Transdermal Drug Delivery Device Revenue by Drug Type (2021-2026) & ($ million)
Table 19. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Drug Type (2021-2026)
Table 20. Global Passive Transdermal Drug Delivery Device Sale Price by Drug Type (2021-2026) & (USD/Unit)
Table 21. Major Players of Diffusion Only Drug Delivery
Table 22. Major Players of Penetration Enhancer Assisted Drug Delivery
Table 23. Major Players of Carrier Mediated Drug Delivery
Table 24. Global Passive Transdermal Drug Delivery Device Sales by Interaction Mechanism (2021-2026) & (Units)
Table 25. Global Passive Transdermal Drug Delivery Device Sales Market Share by Interaction Mechanism (2021-2026)
Table 26. Global Passive Transdermal Drug Delivery Device Revenue by Interaction Mechanism (2021-2026) & ($ million)
Table 27. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Interaction Mechanism (2021-2026)
Table 28. Global Passive Transdermal Drug Delivery Device Sale Price by Interaction Mechanism (2021-2026) & (USD/Unit)
Table 29. Major Players of Immediate Release Drug Delivery
Table 30. Major Players of Sustained Release Drug Delivery
Table 31. Major Players of Controlled Release Drug Delivery
Table 32. Global Passive Transdermal Drug Delivery Device Sales by Drug Release Rate (2021-2026) & (Units)
Table 33. Global Passive Transdermal Drug Delivery Device Sales Market Share by Drug Release Rate (2021-2026)
Table 34. Global Passive Transdermal Drug Delivery Device Revenue by Drug Release Rate (2021-2026) & ($ million)
Table 35. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Drug Release Rate (2021-2026)
Table 36. Global Passive Transdermal Drug Delivery Device Sale Price by Drug Release Rate (2021-2026) & (USD/Unit)
Table 37. Global Passive Transdermal Drug Delivery Device Sale by Application (2021-2026) & (Units)
Table 38. Global Passive Transdermal Drug Delivery Device Sale Market Share by Application (2021-2026)
Table 39. Global Passive Transdermal Drug Delivery Device Revenue by Application (2021-2026) & ($ million)
Table 40. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Application (2021-2026)
Table 41. Global Passive Transdermal Drug Delivery Device Sale Price by Application (2021-2026) & (USD/Unit)
Table 42. Global Passive Transdermal Drug Delivery Device Sales by Company (2021-2026) & (Units)
Table 43. Global Passive Transdermal Drug Delivery Device Sales Market Share by Company (2021-2026)
Table 44. Global Passive Transdermal Drug Delivery Device Revenue by Company (2021-2026) & ($ millions)
Table 45. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Company (2021-2026)
Table 46. Global Passive Transdermal Drug Delivery Device Sale Price by Company (2021-2026) & (USD/Unit)
Table 47. Key Manufacturers Passive Transdermal Drug Delivery Device Producing Area Distribution and Sales Area
Table 48. Players Passive Transdermal Drug Delivery Device Products Offered
Table 49. Passive Transdermal Drug Delivery Device Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 50. New Products and Potential Entrants
Table 51. Market M&A Activity & Strategy
Table 52. Global Passive Transdermal Drug Delivery Device Sales by Geographic Region (2021-2026) & (Units)
Table 53. Global Passive Transdermal Drug Delivery Device Sales Market Share Geographic Region (2021-2026)
Table 54. Global Passive Transdermal Drug Delivery Device Revenue by Geographic Region (2021-2026) & ($ millions)
Table 55. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Geographic Region (2021-2026)
Table 56. Global Passive Transdermal Drug Delivery Device Sales by Country/Region (2021-2026) & (Units)
Table 57. Global Passive Transdermal Drug Delivery Device Sales Market Share by Country/Region (2021-2026)
Table 58. Global Passive Transdermal Drug Delivery Device Revenue by Country/Region (2021-2026) & ($ millions)
Table 59. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Country/Region (2021-2026)
Table 60. Americas Passive Transdermal Drug Delivery Device Sales by Country (2021-2026) & (Units)
Table 61. Americas Passive Transdermal Drug Delivery Device Sales Market Share by Country (2021-2026)
Table 62. Americas Passive Transdermal Drug Delivery Device Revenue by Country (2021-2026) & ($ millions)
Table 63. Americas Passive Transdermal Drug Delivery Device Sales by Type (2021-2026) & (Units)
Table 64. Americas Passive Transdermal Drug Delivery Device Sales by Application (2021-2026) & (Units)
Table 65. APAC Passive Transdermal Drug Delivery Device Sales by Region (2021-2026) & (Units)
Table 66. APAC Passive Transdermal Drug Delivery Device Sales Market Share by Region (2021-2026)
Table 67. APAC Passive Transdermal Drug Delivery Device Revenue by Region (2021-2026) & ($ millions)
Table 68. APAC Passive Transdermal Drug Delivery Device Sales by Type (2021-2026) & (Units)
Table 69. APAC Passive Transdermal Drug Delivery Device Sales by Application (2021-2026) & (Units)
Table 70. Europe Passive Transdermal Drug Delivery Device Sales by Country (2021-2026) & (Units)
Table 71. Europe Passive Transdermal Drug Delivery Device Revenue by Country (2021-2026) & ($ millions)
Table 72. Europe Passive Transdermal Drug Delivery Device Sales by Type (2021-2026) & (Units)
Table 73. Europe Passive Transdermal Drug Delivery Device Sales by Application (2021-2026) & (Units)
Table 74. Middle East & Africa Passive Transdermal Drug Delivery Device Sales by Country (2021-2026) & (Units)
Table 75. Middle East & Africa Passive Transdermal Drug Delivery Device Revenue Market Share by Country (2021-2026)
Table 76. Middle East & Africa Passive Transdermal Drug Delivery Device Sales by Type (2021-2026) & (Units)
Table 77. Middle East & Africa Passive Transdermal Drug Delivery Device Sales by Application (2021-2026) & (Units)
Table 78. Key Market Drivers & Growth Opportunities of Passive Transdermal Drug Delivery Device
Table 79. Key Market Challenges & Risks of Passive Transdermal Drug Delivery Device
Table 80. Key Industry Trends of Passive Transdermal Drug Delivery Device
Table 81. Passive Transdermal Drug Delivery Device Raw Material
Table 82. Key Suppliers of Raw Materials
Table 83. Passive Transdermal Drug Delivery Device Distributors List
Table 84. Passive Transdermal Drug Delivery Device Customer List
Table 85. Global Passive Transdermal Drug Delivery Device Sales Forecast by Region (2027-2032) & (Units)
Table 86. Global Passive Transdermal Drug Delivery Device Revenue Forecast by Region (2027-2032) & ($ millions)
Table 87. Americas Passive Transdermal Drug Delivery Device Sales Forecast by Country (2027-2032) & (Units)
Table 88. Americas Passive Transdermal Drug Delivery Device Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 89. APAC Passive Transdermal Drug Delivery Device Sales Forecast by Region (2027-2032) & (Units)
Table 90. APAC Passive Transdermal Drug Delivery Device Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 91. Europe Passive Transdermal Drug Delivery Device Sales Forecast by Country (2027-2032) & (Units)
Table 92. Europe Passive Transdermal Drug Delivery Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 93. Middle East & Africa Passive Transdermal Drug Delivery Device Sales Forecast by Country (2027-2032) & (Units)
Table 94. Middle East & Africa Passive Transdermal Drug Delivery Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 95. Global Passive Transdermal Drug Delivery Device Sales Forecast by Type (2027-2032) & (Units)
Table 96. Global Passive Transdermal Drug Delivery Device Revenue Forecast by Type (2027-2032) & ($ millions)
Table 97. Global Passive Transdermal Drug Delivery Device Sales Forecast by Application (2027-2032) & (Units)
Table 98. Global Passive Transdermal Drug Delivery Device Revenue Forecast by Application (2027-2032) & ($ millions)
Table 99. Hisamitsu Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 100. Hisamitsu Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 101. Hisamitsu Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 102. Hisamitsu Main Business
Table 103. Hisamitsu Latest Developments
Table 104. LTS Lohmann Therapie-Systeme Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 105. LTS Lohmann Therapie-Systeme Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 106. LTS Lohmann Therapie-Systeme Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 107. LTS Lohmann Therapie-Systeme Main Business
Table 108. LTS Lohmann Therapie-Systeme Latest Developments
Table 109. Teikoku Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 110. Teikoku Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 111. Teikoku Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 112. Teikoku Main Business
Table 113. Teikoku Latest Developments
Table 114. Nitto Denko Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 115. Nitto Denko Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 116. Nitto Denko Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 117. Nitto Denko Main Business
Table 118. Nitto Denko Latest Developments
Table 119. MedPharm Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 120. MedPharm Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 121. MedPharm Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 122. MedPharm Main Business
Table 123. MedPharm Latest Developments
Table 124. NexGel Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 125. NexGel Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 126. NexGel Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 127. NexGel Main Business
Table 128. NexGel Latest Developments
Table 129. Kindeva Drug Delivery Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 130. Kindeva Drug Delivery Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 131. Kindeva Drug Delivery Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 132. Kindeva Drug Delivery Main Business
Table 133. Kindeva Drug Delivery Latest Developments
Table 134. Noven Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 135. Noven Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 136. Noven Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 137. Noven Main Business
Table 138. Noven Latest Developments
Table 139. Teikoku Seiyaku Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 140. Teikoku Seiyaku Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 141. Teikoku Seiyaku Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 142. Teikoku Seiyaku Main Business
Table 143. Teikoku Seiyaku Latest Developments
Table 144. Ildong Pharmaceutical Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 145. Ildong Pharmaceutical Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 146. Ildong Pharmaceutical Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 147. Ildong Pharmaceutical Main Business
Table 148. Ildong Pharmaceutical Latest Developments
Table 149. PassPort Technologies Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 150. PassPort Technologies Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 151. PassPort Technologies Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 152. PassPort Technologies Main Business
Table 153. PassPort Technologies Latest Developments
Table 154. Hayao Group Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 155. Hayao Group Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 156. Hayao Group Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 157. Hayao Group Main Business
Table 158. Hayao Group Latest Developments
Table 159. Lingrui Pharmaceutical Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 160. Lingrui Pharmaceutical Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 161. Lingrui Pharmaceutical Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 162. Lingrui Pharmaceutical Main Business
Table 163. Lingrui Pharmaceutical Latest Developments
Table 164. CAS Microneedle Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 165. CAS Microneedle Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 166. CAS Microneedle Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 167. CAS Microneedle Main Business
Table 168. CAS Microneedle Latest Developments
Table 169. Luye Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 170. Luye Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 171. Luye Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 172. Luye Main Business
Table 173. Luye Latest Developments
Table 174. Tide Pharmaceutical Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 175. Tide Pharmaceutical Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 176. Tide Pharmaceutical Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 177. Tide Pharmaceutical Main Business
Table 178. Tide Pharmaceutical Latest Developments
Table 179. Jiudian Pharmaceutical Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 180. Jiudian Pharmaceutical Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 181. Jiudian Pharmaceutical Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 182. Jiudian Pharmaceutical Main Business
Table 183. Jiudian Pharmaceutical Latest Developments
Table 184. LianSN Pharm Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 185. LianSN Pharm Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 186. LianSN Pharm Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 187. LianSN Pharm Main Business
Table 188. LianSN Pharm Latest Developments
Table 1. Passive Transdermal Drug Delivery Device Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Passive Transdermal Drug Delivery Device Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Patch Drug Delivery
Table 4. Major Players of Cream Drug Delivery
Table 5. Major Players of Plaster Drug Delivery
Table 6. Major Players of Microneedle Drug Delivery
Table 7. Major Players of Liposome Drug Delivery
Table 8. Global Passive Transdermal Drug Delivery Device Sales by Type (2021-2026) & (Units)
Table 9. Global Passive Transdermal Drug Delivery Device Sales Market Share by Type (2021-2026)
Table 10. Global Passive Transdermal Drug Delivery Device Revenue by Type (2021-2026) & ($ million)
Table 11. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Type (2021-2026)
Table 12. Global Passive Transdermal Drug Delivery Device Sale Price by Type (2021-2026) & (USD/Unit)
Table 13. Major Players of Small Molecule Drugs
Table 14. Major Players of Protein Drugs
Table 15. Major Players of Nucleic Acid Drugs
Table 16. Global Passive Transdermal Drug Delivery Device Sales by Drug Type (2021-2026) & (Units)
Table 17. Global Passive Transdermal Drug Delivery Device Sales Market Share by Drug Type (2021-2026)
Table 18. Global Passive Transdermal Drug Delivery Device Revenue by Drug Type (2021-2026) & ($ million)
Table 19. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Drug Type (2021-2026)
Table 20. Global Passive Transdermal Drug Delivery Device Sale Price by Drug Type (2021-2026) & (USD/Unit)
Table 21. Major Players of Diffusion Only Drug Delivery
Table 22. Major Players of Penetration Enhancer Assisted Drug Delivery
Table 23. Major Players of Carrier Mediated Drug Delivery
Table 24. Global Passive Transdermal Drug Delivery Device Sales by Interaction Mechanism (2021-2026) & (Units)
Table 25. Global Passive Transdermal Drug Delivery Device Sales Market Share by Interaction Mechanism (2021-2026)
Table 26. Global Passive Transdermal Drug Delivery Device Revenue by Interaction Mechanism (2021-2026) & ($ million)
Table 27. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Interaction Mechanism (2021-2026)
Table 28. Global Passive Transdermal Drug Delivery Device Sale Price by Interaction Mechanism (2021-2026) & (USD/Unit)
Table 29. Major Players of Immediate Release Drug Delivery
Table 30. Major Players of Sustained Release Drug Delivery
Table 31. Major Players of Controlled Release Drug Delivery
Table 32. Global Passive Transdermal Drug Delivery Device Sales by Drug Release Rate (2021-2026) & (Units)
Table 33. Global Passive Transdermal Drug Delivery Device Sales Market Share by Drug Release Rate (2021-2026)
Table 34. Global Passive Transdermal Drug Delivery Device Revenue by Drug Release Rate (2021-2026) & ($ million)
Table 35. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Drug Release Rate (2021-2026)
Table 36. Global Passive Transdermal Drug Delivery Device Sale Price by Drug Release Rate (2021-2026) & (USD/Unit)
Table 37. Global Passive Transdermal Drug Delivery Device Sale by Application (2021-2026) & (Units)
Table 38. Global Passive Transdermal Drug Delivery Device Sale Market Share by Application (2021-2026)
Table 39. Global Passive Transdermal Drug Delivery Device Revenue by Application (2021-2026) & ($ million)
Table 40. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Application (2021-2026)
Table 41. Global Passive Transdermal Drug Delivery Device Sale Price by Application (2021-2026) & (USD/Unit)
Table 42. Global Passive Transdermal Drug Delivery Device Sales by Company (2021-2026) & (Units)
Table 43. Global Passive Transdermal Drug Delivery Device Sales Market Share by Company (2021-2026)
Table 44. Global Passive Transdermal Drug Delivery Device Revenue by Company (2021-2026) & ($ millions)
Table 45. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Company (2021-2026)
Table 46. Global Passive Transdermal Drug Delivery Device Sale Price by Company (2021-2026) & (USD/Unit)
Table 47. Key Manufacturers Passive Transdermal Drug Delivery Device Producing Area Distribution and Sales Area
Table 48. Players Passive Transdermal Drug Delivery Device Products Offered
Table 49. Passive Transdermal Drug Delivery Device Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 50. New Products and Potential Entrants
Table 51. Market M&A Activity & Strategy
Table 52. Global Passive Transdermal Drug Delivery Device Sales by Geographic Region (2021-2026) & (Units)
Table 53. Global Passive Transdermal Drug Delivery Device Sales Market Share Geographic Region (2021-2026)
Table 54. Global Passive Transdermal Drug Delivery Device Revenue by Geographic Region (2021-2026) & ($ millions)
Table 55. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Geographic Region (2021-2026)
Table 56. Global Passive Transdermal Drug Delivery Device Sales by Country/Region (2021-2026) & (Units)
Table 57. Global Passive Transdermal Drug Delivery Device Sales Market Share by Country/Region (2021-2026)
Table 58. Global Passive Transdermal Drug Delivery Device Revenue by Country/Region (2021-2026) & ($ millions)
Table 59. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Country/Region (2021-2026)
Table 60. Americas Passive Transdermal Drug Delivery Device Sales by Country (2021-2026) & (Units)
Table 61. Americas Passive Transdermal Drug Delivery Device Sales Market Share by Country (2021-2026)
Table 62. Americas Passive Transdermal Drug Delivery Device Revenue by Country (2021-2026) & ($ millions)
Table 63. Americas Passive Transdermal Drug Delivery Device Sales by Type (2021-2026) & (Units)
Table 64. Americas Passive Transdermal Drug Delivery Device Sales by Application (2021-2026) & (Units)
Table 65. APAC Passive Transdermal Drug Delivery Device Sales by Region (2021-2026) & (Units)
Table 66. APAC Passive Transdermal Drug Delivery Device Sales Market Share by Region (2021-2026)
Table 67. APAC Passive Transdermal Drug Delivery Device Revenue by Region (2021-2026) & ($ millions)
Table 68. APAC Passive Transdermal Drug Delivery Device Sales by Type (2021-2026) & (Units)
Table 69. APAC Passive Transdermal Drug Delivery Device Sales by Application (2021-2026) & (Units)
Table 70. Europe Passive Transdermal Drug Delivery Device Sales by Country (2021-2026) & (Units)
Table 71. Europe Passive Transdermal Drug Delivery Device Revenue by Country (2021-2026) & ($ millions)
Table 72. Europe Passive Transdermal Drug Delivery Device Sales by Type (2021-2026) & (Units)
Table 73. Europe Passive Transdermal Drug Delivery Device Sales by Application (2021-2026) & (Units)
Table 74. Middle East & Africa Passive Transdermal Drug Delivery Device Sales by Country (2021-2026) & (Units)
Table 75. Middle East & Africa Passive Transdermal Drug Delivery Device Revenue Market Share by Country (2021-2026)
Table 76. Middle East & Africa Passive Transdermal Drug Delivery Device Sales by Type (2021-2026) & (Units)
Table 77. Middle East & Africa Passive Transdermal Drug Delivery Device Sales by Application (2021-2026) & (Units)
Table 78. Key Market Drivers & Growth Opportunities of Passive Transdermal Drug Delivery Device
Table 79. Key Market Challenges & Risks of Passive Transdermal Drug Delivery Device
Table 80. Key Industry Trends of Passive Transdermal Drug Delivery Device
Table 81. Passive Transdermal Drug Delivery Device Raw Material
Table 82. Key Suppliers of Raw Materials
Table 83. Passive Transdermal Drug Delivery Device Distributors List
Table 84. Passive Transdermal Drug Delivery Device Customer List
Table 85. Global Passive Transdermal Drug Delivery Device Sales Forecast by Region (2027-2032) & (Units)
Table 86. Global Passive Transdermal Drug Delivery Device Revenue Forecast by Region (2027-2032) & ($ millions)
Table 87. Americas Passive Transdermal Drug Delivery Device Sales Forecast by Country (2027-2032) & (Units)
Table 88. Americas Passive Transdermal Drug Delivery Device Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 89. APAC Passive Transdermal Drug Delivery Device Sales Forecast by Region (2027-2032) & (Units)
Table 90. APAC Passive Transdermal Drug Delivery Device Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 91. Europe Passive Transdermal Drug Delivery Device Sales Forecast by Country (2027-2032) & (Units)
Table 92. Europe Passive Transdermal Drug Delivery Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 93. Middle East & Africa Passive Transdermal Drug Delivery Device Sales Forecast by Country (2027-2032) & (Units)
Table 94. Middle East & Africa Passive Transdermal Drug Delivery Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 95. Global Passive Transdermal Drug Delivery Device Sales Forecast by Type (2027-2032) & (Units)
Table 96. Global Passive Transdermal Drug Delivery Device Revenue Forecast by Type (2027-2032) & ($ millions)
Table 97. Global Passive Transdermal Drug Delivery Device Sales Forecast by Application (2027-2032) & (Units)
Table 98. Global Passive Transdermal Drug Delivery Device Revenue Forecast by Application (2027-2032) & ($ millions)
Table 99. Hisamitsu Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 100. Hisamitsu Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 101. Hisamitsu Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 102. Hisamitsu Main Business
Table 103. Hisamitsu Latest Developments
Table 104. LTS Lohmann Therapie-Systeme Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 105. LTS Lohmann Therapie-Systeme Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 106. LTS Lohmann Therapie-Systeme Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 107. LTS Lohmann Therapie-Systeme Main Business
Table 108. LTS Lohmann Therapie-Systeme Latest Developments
Table 109. Teikoku Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 110. Teikoku Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 111. Teikoku Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 112. Teikoku Main Business
Table 113. Teikoku Latest Developments
Table 114. Nitto Denko Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 115. Nitto Denko Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 116. Nitto Denko Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 117. Nitto Denko Main Business
Table 118. Nitto Denko Latest Developments
Table 119. MedPharm Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 120. MedPharm Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 121. MedPharm Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 122. MedPharm Main Business
Table 123. MedPharm Latest Developments
Table 124. NexGel Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 125. NexGel Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 126. NexGel Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 127. NexGel Main Business
Table 128. NexGel Latest Developments
Table 129. Kindeva Drug Delivery Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 130. Kindeva Drug Delivery Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 131. Kindeva Drug Delivery Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 132. Kindeva Drug Delivery Main Business
Table 133. Kindeva Drug Delivery Latest Developments
Table 134. Noven Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 135. Noven Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 136. Noven Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 137. Noven Main Business
Table 138. Noven Latest Developments
Table 139. Teikoku Seiyaku Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 140. Teikoku Seiyaku Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 141. Teikoku Seiyaku Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 142. Teikoku Seiyaku Main Business
Table 143. Teikoku Seiyaku Latest Developments
Table 144. Ildong Pharmaceutical Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 145. Ildong Pharmaceutical Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 146. Ildong Pharmaceutical Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 147. Ildong Pharmaceutical Main Business
Table 148. Ildong Pharmaceutical Latest Developments
Table 149. PassPort Technologies Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 150. PassPort Technologies Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 151. PassPort Technologies Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 152. PassPort Technologies Main Business
Table 153. PassPort Technologies Latest Developments
Table 154. Hayao Group Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 155. Hayao Group Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 156. Hayao Group Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 157. Hayao Group Main Business
Table 158. Hayao Group Latest Developments
Table 159. Lingrui Pharmaceutical Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 160. Lingrui Pharmaceutical Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 161. Lingrui Pharmaceutical Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 162. Lingrui Pharmaceutical Main Business
Table 163. Lingrui Pharmaceutical Latest Developments
Table 164. CAS Microneedle Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 165. CAS Microneedle Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 166. CAS Microneedle Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 167. CAS Microneedle Main Business
Table 168. CAS Microneedle Latest Developments
Table 169. Luye Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 170. Luye Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 171. Luye Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 172. Luye Main Business
Table 173. Luye Latest Developments
Table 174. Tide Pharmaceutical Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 175. Tide Pharmaceutical Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 176. Tide Pharmaceutical Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 177. Tide Pharmaceutical Main Business
Table 178. Tide Pharmaceutical Latest Developments
Table 179. Jiudian Pharmaceutical Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 180. Jiudian Pharmaceutical Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 181. Jiudian Pharmaceutical Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 182. Jiudian Pharmaceutical Main Business
Table 183. Jiudian Pharmaceutical Latest Developments
Table 184. LianSN Pharm Basic Information, Passive Transdermal Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 185. LianSN Pharm Passive Transdermal Drug Delivery Device Product Portfolios and Specifications
Table 186. LianSN Pharm Passive Transdermal Drug Delivery Device Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 187. LianSN Pharm Main Business
Table 188. LianSN Pharm Latest Developments
LIST OF FIGURES
Figure 1. Picture of Passive Transdermal Drug Delivery Device
Figure 2. Passive Transdermal Drug Delivery Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Passive Transdermal Drug Delivery Device Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Passive Transdermal Drug Delivery Device Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Passive Transdermal Drug Delivery Device Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Passive Transdermal Drug Delivery Device Sales Market Share by Country/Region (2025)
Figure 10. Passive Transdermal Drug Delivery Device Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Patch Drug Delivery
Figure 12. Product Picture of Cream Drug Delivery
Figure 13. Product Picture of Plaster Drug Delivery
Figure 14. Product Picture of Microneedle Drug Delivery
Figure 15. Product Picture of Liposome Drug Delivery
Figure 16. Global Passive Transdermal Drug Delivery Device Sales Market Share by Type in 2026
Figure 17. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Type (2021-2026)
Figure 18. Product Picture of Small Molecule Drugs
Figure 19. Product Picture of Protein Drugs
Figure 20. Product Picture of Nucleic Acid Drugs
Figure 21. Global Passive Transdermal Drug Delivery Device Sales Market Share by Drug Type in 2026
Figure 22. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Drug Type (2021-2026)
Figure 23. Product Picture of Diffusion Only Drug Delivery
Figure 24. Product Picture of Penetration Enhancer Assisted Drug Delivery
Figure 25. Product Picture of Carrier Mediated Drug Delivery
Figure 26. Global Passive Transdermal Drug Delivery Device Sales Market Share by Interaction Mechanism in 2026
Figure 27. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Interaction Mechanism (2021-2026)
Figure 28. Product Picture of Immediate Release Drug Delivery
Figure 29. Product Picture of Sustained Release Drug Delivery
Figure 30. Product Picture of Controlled Release Drug Delivery
Figure 31. Global Passive Transdermal Drug Delivery Device Sales Market Share by Drug Release Rate in 2026
Figure 32. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Drug Release Rate (2021-2026)
Figure 33. Passive Transdermal Drug Delivery Device Consumed in Neurological Disorders Treatment
Figure 34. Global Passive Transdermal Drug Delivery Device Market: Neurological Disorders Treatment (2021-2026) & (Units)
Figure 35. Passive Transdermal Drug Delivery Device Consumed in Cardiovascular Diseases Treatment
Figure 36. Global Passive Transdermal Drug Delivery Device Market: Cardiovascular Diseases Treatment (2021-2026) & (Units)
Figure 37. Passive Transdermal Drug Delivery Device Consumed in Hormone Replacement Therapy
Figure 38. Global Passive Transdermal Drug Delivery Device Market: Hormone Replacement Therapy (2021-2026) & (Units)
Figure 39. Global Passive Transdermal Drug Delivery Device Sale Market Share by Application (2025)
Figure 40. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Application in 2025
Figure 41. Passive Transdermal Drug Delivery Device Sales by Company in 2025 (Units)
Figure 42. Global Passive Transdermal Drug Delivery Device Sales Market Share by Company in 2025
Figure 43. Passive Transdermal Drug Delivery Device Revenue by Company in 2025 ($ millions)
Figure 44. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Company in 2025
Figure 45. Global Passive Transdermal Drug Delivery Device Sales Market Share by Geographic Region (2021-2026)
Figure 46. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Geographic Region in 2025
Figure 47. Americas Passive Transdermal Drug Delivery Device Sales 2021-2026 (Units)
Figure 48. Americas Passive Transdermal Drug Delivery Device Revenue 2021-2026 ($ millions)
Figure 49. APAC Passive Transdermal Drug Delivery Device Sales 2021-2026 (Units)
Figure 50. APAC Passive Transdermal Drug Delivery Device Revenue 2021-2026 ($ millions)
Figure 51. Europe Passive Transdermal Drug Delivery Device Sales 2021-2026 (Units)
Figure 52. Europe Passive Transdermal Drug Delivery Device Revenue 2021-2026 ($ millions)
Figure 53. Middle East & Africa Passive Transdermal Drug Delivery Device Sales 2021-2026 (Units)
Figure 54. Middle East & Africa Passive Transdermal Drug Delivery Device Revenue 2021-2026 ($ millions)
Figure 55. Americas Passive Transdermal Drug Delivery Device Sales Market Share by Country in 2025
Figure 56. Americas Passive Transdermal Drug Delivery Device Revenue Market Share by Country (2021-2026)
Figure 57. Americas Passive Transdermal Drug Delivery Device Sales Market Share by Type (2021-2026)
Figure 58. Americas Passive Transdermal Drug Delivery Device Sales Market Share by Application (2021-2026)
Figure 59. United States Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 60. Canada Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 61. Mexico Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 62. Brazil Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 63. APAC Passive Transdermal Drug Delivery Device Sales Market Share by Region in 2025
Figure 64. APAC Passive Transdermal Drug Delivery Device Revenue Market Share by Region (2021-2026)
Figure 65. APAC Passive Transdermal Drug Delivery Device Sales Market Share by Type (2021-2026)
Figure 66. APAC Passive Transdermal Drug Delivery Device Sales Market Share by Application (2021-2026)
Figure 67. China Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 68. Japan Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 69. South Korea Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 70. Southeast Asia Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 71. India Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 72. Australia Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 73. China Taiwan Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 74. Europe Passive Transdermal Drug Delivery Device Sales Market Share by Country in 2025
Figure 75. Europe Passive Transdermal Drug Delivery Device Revenue Market Share by Country (2021-2026)
Figure 76. Europe Passive Transdermal Drug Delivery Device Sales Market Share by Type (2021-2026)
Figure 77. Europe Passive Transdermal Drug Delivery Device Sales Market Share by Application (2021-2026)
Figure 78. Germany Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 79. France Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 80. UK Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 81. Italy Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 82. Russia Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 83. Middle East & Africa Passive Transdermal Drug Delivery Device Sales Market Share by Country (2021-2026)
Figure 84. Middle East & Africa Passive Transdermal Drug Delivery Device Sales Market Share by Type (2021-2026)
Figure 85. Middle East & Africa Passive Transdermal Drug Delivery Device Sales Market Share by Application (2021-2026)
Figure 86. Egypt Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 87. South Africa Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 88. Israel Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 89. Turkey Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 90. GCC Countries Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 91. Manufacturing Cost Structure Analysis of Passive Transdermal Drug Delivery Device in 2026
Figure 92. Manufacturing Process Analysis of Passive Transdermal Drug Delivery Device
Figure 93. Industry Chain Structure of Passive Transdermal Drug Delivery Device
Figure 94. Channels of Distribution
Figure 95. Global Passive Transdermal Drug Delivery Device Sales Market Forecast by Region (2027-2032)
Figure 96. Global Passive Transdermal Drug Delivery Device Revenue Market Share Forecast by Region (2027-2032)
Figure 97. Global Passive Transdermal Drug Delivery Device Sales Market Share Forecast by Type (2027-2032)
Figure 98. Global Passive Transdermal Drug Delivery Device Revenue Market Share Forecast by Type (2027-2032)
Figure 99. Global Passive Transdermal Drug Delivery Device Sales Market Share Forecast by Application (2027-2032)
Figure 100. Global Passive Transdermal Drug Delivery Device Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Passive Transdermal Drug Delivery Device
Figure 2. Passive Transdermal Drug Delivery Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Passive Transdermal Drug Delivery Device Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Passive Transdermal Drug Delivery Device Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Passive Transdermal Drug Delivery Device Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Passive Transdermal Drug Delivery Device Sales Market Share by Country/Region (2025)
Figure 10. Passive Transdermal Drug Delivery Device Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Patch Drug Delivery
Figure 12. Product Picture of Cream Drug Delivery
Figure 13. Product Picture of Plaster Drug Delivery
Figure 14. Product Picture of Microneedle Drug Delivery
Figure 15. Product Picture of Liposome Drug Delivery
Figure 16. Global Passive Transdermal Drug Delivery Device Sales Market Share by Type in 2026
Figure 17. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Type (2021-2026)
Figure 18. Product Picture of Small Molecule Drugs
Figure 19. Product Picture of Protein Drugs
Figure 20. Product Picture of Nucleic Acid Drugs
Figure 21. Global Passive Transdermal Drug Delivery Device Sales Market Share by Drug Type in 2026
Figure 22. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Drug Type (2021-2026)
Figure 23. Product Picture of Diffusion Only Drug Delivery
Figure 24. Product Picture of Penetration Enhancer Assisted Drug Delivery
Figure 25. Product Picture of Carrier Mediated Drug Delivery
Figure 26. Global Passive Transdermal Drug Delivery Device Sales Market Share by Interaction Mechanism in 2026
Figure 27. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Interaction Mechanism (2021-2026)
Figure 28. Product Picture of Immediate Release Drug Delivery
Figure 29. Product Picture of Sustained Release Drug Delivery
Figure 30. Product Picture of Controlled Release Drug Delivery
Figure 31. Global Passive Transdermal Drug Delivery Device Sales Market Share by Drug Release Rate in 2026
Figure 32. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Drug Release Rate (2021-2026)
Figure 33. Passive Transdermal Drug Delivery Device Consumed in Neurological Disorders Treatment
Figure 34. Global Passive Transdermal Drug Delivery Device Market: Neurological Disorders Treatment (2021-2026) & (Units)
Figure 35. Passive Transdermal Drug Delivery Device Consumed in Cardiovascular Diseases Treatment
Figure 36. Global Passive Transdermal Drug Delivery Device Market: Cardiovascular Diseases Treatment (2021-2026) & (Units)
Figure 37. Passive Transdermal Drug Delivery Device Consumed in Hormone Replacement Therapy
Figure 38. Global Passive Transdermal Drug Delivery Device Market: Hormone Replacement Therapy (2021-2026) & (Units)
Figure 39. Global Passive Transdermal Drug Delivery Device Sale Market Share by Application (2025)
Figure 40. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Application in 2025
Figure 41. Passive Transdermal Drug Delivery Device Sales by Company in 2025 (Units)
Figure 42. Global Passive Transdermal Drug Delivery Device Sales Market Share by Company in 2025
Figure 43. Passive Transdermal Drug Delivery Device Revenue by Company in 2025 ($ millions)
Figure 44. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Company in 2025
Figure 45. Global Passive Transdermal Drug Delivery Device Sales Market Share by Geographic Region (2021-2026)
Figure 46. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Geographic Region in 2025
Figure 47. Americas Passive Transdermal Drug Delivery Device Sales 2021-2026 (Units)
Figure 48. Americas Passive Transdermal Drug Delivery Device Revenue 2021-2026 ($ millions)
Figure 49. APAC Passive Transdermal Drug Delivery Device Sales 2021-2026 (Units)
Figure 50. APAC Passive Transdermal Drug Delivery Device Revenue 2021-2026 ($ millions)
Figure 51. Europe Passive Transdermal Drug Delivery Device Sales 2021-2026 (Units)
Figure 52. Europe Passive Transdermal Drug Delivery Device Revenue 2021-2026 ($ millions)
Figure 53. Middle East & Africa Passive Transdermal Drug Delivery Device Sales 2021-2026 (Units)
Figure 54. Middle East & Africa Passive Transdermal Drug Delivery Device Revenue 2021-2026 ($ millions)
Figure 55. Americas Passive Transdermal Drug Delivery Device Sales Market Share by Country in 2025
Figure 56. Americas Passive Transdermal Drug Delivery Device Revenue Market Share by Country (2021-2026)
Figure 57. Americas Passive Transdermal Drug Delivery Device Sales Market Share by Type (2021-2026)
Figure 58. Americas Passive Transdermal Drug Delivery Device Sales Market Share by Application (2021-2026)
Figure 59. United States Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 60. Canada Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 61. Mexico Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 62. Brazil Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 63. APAC Passive Transdermal Drug Delivery Device Sales Market Share by Region in 2025
Figure 64. APAC Passive Transdermal Drug Delivery Device Revenue Market Share by Region (2021-2026)
Figure 65. APAC Passive Transdermal Drug Delivery Device Sales Market Share by Type (2021-2026)
Figure 66. APAC Passive Transdermal Drug Delivery Device Sales Market Share by Application (2021-2026)
Figure 67. China Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 68. Japan Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 69. South Korea Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 70. Southeast Asia Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 71. India Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 72. Australia Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 73. China Taiwan Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 74. Europe Passive Transdermal Drug Delivery Device Sales Market Share by Country in 2025
Figure 75. Europe Passive Transdermal Drug Delivery Device Revenue Market Share by Country (2021-2026)
Figure 76. Europe Passive Transdermal Drug Delivery Device Sales Market Share by Type (2021-2026)
Figure 77. Europe Passive Transdermal Drug Delivery Device Sales Market Share by Application (2021-2026)
Figure 78. Germany Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 79. France Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 80. UK Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 81. Italy Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 82. Russia Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 83. Middle East & Africa Passive Transdermal Drug Delivery Device Sales Market Share by Country (2021-2026)
Figure 84. Middle East & Africa Passive Transdermal Drug Delivery Device Sales Market Share by Type (2021-2026)
Figure 85. Middle East & Africa Passive Transdermal Drug Delivery Device Sales Market Share by Application (2021-2026)
Figure 86. Egypt Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 87. South Africa Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 88. Israel Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 89. Turkey Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 90. GCC Countries Passive Transdermal Drug Delivery Device Revenue Growth 2021-2026 ($ millions)
Figure 91. Manufacturing Cost Structure Analysis of Passive Transdermal Drug Delivery Device in 2026
Figure 92. Manufacturing Process Analysis of Passive Transdermal Drug Delivery Device
Figure 93. Industry Chain Structure of Passive Transdermal Drug Delivery Device
Figure 94. Channels of Distribution
Figure 95. Global Passive Transdermal Drug Delivery Device Sales Market Forecast by Region (2027-2032)
Figure 96. Global Passive Transdermal Drug Delivery Device Revenue Market Share Forecast by Region (2027-2032)
Figure 97. Global Passive Transdermal Drug Delivery Device Sales Market Share Forecast by Type (2027-2032)
Figure 98. Global Passive Transdermal Drug Delivery Device Revenue Market Share Forecast by Type (2027-2032)
Figure 99. Global Passive Transdermal Drug Delivery Device Sales Market Share Forecast by Application (2027-2032)
Figure 100. Global Passive Transdermal Drug Delivery Device Revenue Market Share Forecast by Application (2027-2032)
